Effect of baicalin on pharmacokinetics of chlorogenic acid in rabbits
OBJECTIVE: The objective of this paper is to investigate the pharmacokinetics of Chlorogenic acid (CA)and CA-Baicalin compound after intravenous injection (iv) in rabbits.
METHOD: Ten rabbits were randomly divided into two groups. One group were administered CA (6 mg x kg(-1)) by iv, while the other were treated with CA (6 mg x kg(-1))-baicalin (90 mg x kg(-1)) compound by iv. administration. The concentration of CA in plasma was determined by HPLC. The key parameters of pharmacokinetics were calculated and analyzed by kinetic software.
RESULT: Both Concentration-time courses of CA alone and CA-Baicalin compound were consistent with a two-compartment model after administration. The key pharmacokinetic parameters of CA alone were significantly different from that of CA-Baicalin compound (P < 0.05). Compared with the group treated with CA alone, the group treated with CA-Baicalin compound had dramatic increased in AUC(0-infinity), MRT and T1/2alpha.
CONCLUSION: There are significant difference between the pharmacokinetics of CA and CA-Baicalin compound in rabbits. Baicalin has impact on the pharmacokinetics of CA in rabbits.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2010 |
---|---|
Erschienen: |
2010 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica - 35(2010), 24 vom: 01. Dez., Seite 3291-3 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Li, Zhaoxi [VerfasserIn] |
---|
Themen: |
318ADP12RI |
---|
Anmerkungen: |
Date Completed 12.04.2011 Date Revised 21.11.2013 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM20696059X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM20696059X | ||
003 | DE-627 | ||
005 | 20231224001045.0 | ||
007 | tu | ||
008 | 231224s2010 xx ||||| 00| ||chi c | ||
028 | 5 | 2 | |a pubmed24n0690.xml |
035 | |a (DE-627)NLM20696059X | ||
035 | |a (NLM)21438392 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Li, Zhaoxi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of baicalin on pharmacokinetics of chlorogenic acid in rabbits |
264 | 1 | |c 2010 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 12.04.2011 | ||
500 | |a Date Revised 21.11.2013 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: The objective of this paper is to investigate the pharmacokinetics of Chlorogenic acid (CA)and CA-Baicalin compound after intravenous injection (iv) in rabbits | ||
520 | |a METHOD: Ten rabbits were randomly divided into two groups. One group were administered CA (6 mg x kg(-1)) by iv, while the other were treated with CA (6 mg x kg(-1))-baicalin (90 mg x kg(-1)) compound by iv. administration. The concentration of CA in plasma was determined by HPLC. The key parameters of pharmacokinetics were calculated and analyzed by kinetic software | ||
520 | |a RESULT: Both Concentration-time courses of CA alone and CA-Baicalin compound were consistent with a two-compartment model after administration. The key pharmacokinetic parameters of CA alone were significantly different from that of CA-Baicalin compound (P < 0.05). Compared with the group treated with CA alone, the group treated with CA-Baicalin compound had dramatic increased in AUC(0-infinity), MRT and T1/2alpha | ||
520 | |a CONCLUSION: There are significant difference between the pharmacokinetics of CA and CA-Baicalin compound in rabbits. Baicalin has impact on the pharmacokinetics of CA in rabbits | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Flavonoids |2 NLM | |
650 | 7 | |a Chlorogenic Acid |2 NLM | |
650 | 7 | |a 318ADP12RI |2 NLM | |
650 | 7 | |a baicalin |2 NLM | |
650 | 7 | |a 347Q89U4M5 |2 NLM | |
700 | 1 | |a Ni, Jian |e verfasserin |4 aut | |
700 | 1 | |a Fang, Guannan |e verfasserin |4 aut | |
700 | 1 | |a Gao, Yeli |e verfasserin |4 aut | |
700 | 1 | |a Wei, Jia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica |d 1989 |g 35(2010), 24 vom: 01. Dez., Seite 3291-3 |w (DE-627)NLM012733113 |x 1001-5302 |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2010 |g number:24 |g day:01 |g month:12 |g pages:3291-3 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2010 |e 24 |b 01 |c 12 |h 3291-3 |